309 results about "Ancylobacter sp." patented technology

The invention discloses a bacillus strain H7 and an application thereof. The invention provides bacillus velezensis H7 or a progeny of the bacillus velezensis H7, and the preservation number of the bacillus velezensis H7 in the China Center for Type Culture Collection (CCTCC) is CCTCC NO: M 2025630. The bacillus velezensis H7 disclosed by the invention has a very good antibacterial effect on various common clinical pathogenic bacteria (including klebsiella pneumoniae, escherichia coli, candida albicans, enterobacter cloacae complex, acinetobacter baumannii and the like), and particularly shows a very high inhibition rate on some drug-resistant clinical pathogenic bacteria; therefore, the compound has important application value in development of drug and non-drug antibacterial products (such as medical antibacterial materials and the like), a new choice can be provided for drug and non-drug prevention and control of clinical pathogenic bacterium infection, and particularly, the compound has a supplementary effect in the aspects of reducing drug-resistant bacterium propagation risk and reducing drug dependence.

The present invention addresses the problem of providing a microorganism which has less load on the environment, has excellent capability of controlling various plant diseases, and can be effectively utilized for the control of plant diseases and the like in the form of cells, a culture product of the cells, or a culture supernatant contained in the culture product.　The problem can be solved by using Bacillus sp. 201106_1 strain (NITE BP-03884 strain).

Provided are a mixture of three species of Lactobacillus fermentum strain and Lactobacillus plantarum strain and use thereof. A composition according to one aspect including, as an active ingredient, a mixture of Lactobacillus fermentum strains GB102 and GB103 and Lactobacillus plantarum strain GB104; or a lysate or culture solution thereof, or an extract of the culture solution, can be usefully used for the prevention or treatment of muscle-related disorders or obesity by alleviating the decrease in grip strength induced by aging or reducing the change in intestinal microbial environment induced by aging.

Provided is a composition for controlling uptake of microparticles into a body, the composition containing a lactic acid bacterium. The lactic acid bacterium is preferably any one selected from bacteria belonging to the genus Lactobacillus and bacteria belonging to the genus Streptococcus. For example, the lactic acid bacterium is a bacterium belonging to Lactobacillus delbrueckii, Lactobacillus paracasei, Lactobacillus gasseri, or Streptococcus thermophilus.

The invention discloses a pseudoarthrobacter sp. T64 for promoting soybean growth and wheat yield increase in saline-alkali soil and application of the pseudoarthrobacter sp. T64. The classification name of the pseudoarthrobacter sp. Is pseudoarthrobacter sp., the strain is preserved in the China General Microbiological Culture Collection Center (CGMCC) on October 20, 2025, and the preservation number of the strain is CGMCC No.36271. The invention further discloses a preparation method of the pseudoarthrobacter sp. The addition of the pseudoarthrobacter T64 can effectively promote soybean growth and wheat yield increase in the saline-alkali soil.

The present invention relates to microencapsulated preparations comprising biopesticide, bio-fungicide, and plant growth promoting agents and uses thereof, as well as to methods for controlling pests and for producing said preparations for managing insect pests. In particular, the invention relates to microencapsulated preparations comprising at least one insect-pathogenic (entomopathogenic) fungus selected from Metarhizium spp. and Beauveria bassiana, and at least one pathogenic Bacillus spp. bacterial strain, preparations and particles comprising these, their use on plant material, methods for controlling pests therewith, and processes for their production.

The present disclosure relates to Bacillus velezensis (B. velezensis) and a use thereof, and belongs to the technical field of microorganisms. The present disclosure solves one of the problems of the Bacillus in the art such as poor broad-spectrum activity for fungi and bacteria, low inhibitory activity, and limited inhibition range. The B. velezensis QMHF-G5 has an excellent inhibitory activity for pathogenic fungi and bacteria, and can inhibit a variety of pathogenic fungi and bacteria, with a prominent broad-spectrum activity. In addition, the B. velezensis has a high inhibitory activity for a variety of pathogenic fungi and bacteria detected, with a high inhibition rate.

The invention relates to an antibacterial peptide and application thereof. The amino acid sequence of the antibacterial peptide is as shown in SEQ ID No. 1. The antibacterial peptide has excellent broad-spectrum antibacterial activity, for example, the antibacterial peptide has antibacterial activity on bacteria of the genus Staphylococcus (Staphylococcus), the genus Acinetobacter (Acinetobacter) and the genus Bacillus (Bacillus). Under the background that the global bacterial drug resistance problem is increasingly severe and traditional antibiotics gradually lose efficacy on multi-drug-resistant bacteria, a new treatment means is provided for treating bacteria such as methicillin-resistant staphylococcus aureus, carbapenem-resistant acinetobacter baumannii and bacillus subtilis which bring huge threats to public health. And a new possibility is provided for solving the problem that no medicine can be used clinically.

Bacillus strains useful for preventing and / or controlling Clostridium perfringens infections and necrotic enteritis in monogastric animals, such as swine and poultry, and for improving the overall health, feed conversion rates and body weight gain of such animals, as well as compositions comprising the Bacillus strains and various methods of using the Bacillus strains in animal feed and animal feed additives.

Modified bacterial strain of the Pseudomonas sp. genus, the strain of Pseudomonas stutzeri deposited under Deposit Accession No. RGM3505 and a modified bacterial strain of the Bacillus sp. genus, a strain of Bacillus velezensis deposited under Accession No. RGM3504. The strains may be combined at a Pseudomonas stutzeri to Bacillus velezensis ratio from 1 :10 to 10:1 CFU / mL. The strains were modified to have greater chemotactic attraction towards plant roots and to improve the beneficial features of crops, for example, of legumes.

The objective of this invention is to provide: aerobic-tolerant Bifidobacterium spp. capable of being cultured under aerobic conditions, a method for culturing the same and a method for screening it, and a composition comprising aerobic-tolerant Bifidobacterium spp. and a method for manufacturing the same. The present invention that solves this problem is a method for culturing Bifidobacterium bacteria, comprising the step of culturing Bifidobacterium bacteria having any one of the following (1) to (7) under aerobic conditions: (1) a gene consisting of a base sequence shown in sequence number 1 or 2; (2) a gene having more than 90% identity with a base sequence shown in sequence number 1 or 2; (3) a gene consisting of a base sequence in which 1 to several bases are missing, substituted, or added to a base sequence shown in sequence number 1 or 2; (4) a gene consisting of a base sequence of DNA that can hybridize under strict conditions with a DNA consisting of a complementary sequence of a base sequence shown in sequence number 1 or 2; (5) a gene consisting of a degenerate isomer of a base sequence shown in sequence number 1 or 2; (6) a gene encoding a protein consisting of an amino acid sequence shown in sequence number 3 or 4; (7) a gene encoding a protein consisting of an amino acid sequence in which 1 to several amino acids are missing, substituted, or added to an amino acid sequence shown in sequence number 3 or 4.

The present application relates to a strain of Inhernia Bacillus and its application in ramie degumming, the strain is preserved in Guangdong Microbial Culture Collection Center on September 15, 2025, and the preservation number is GDMCC NO: 66966. When the strain is applied to ramie degumming, the degumming reaction can be carried out at a higher temperature, the degumming efficiency of ramie is effectively improved, the fiber is not damaged, the quality of the fiber is improved, and the strain has high application value in ramie degumming.

The invention discloses a novel acinetobacter baumannii phage vBAbaMpha0264 and application thereof, and belongs to the technical field of microorganisms. The acinetobacter baumannii phage vBAbaMpha0264 is preserved in the Guangdong Microbiological Culture Collection Center on August 28, 2025, the preservation number of the acinetobacter baumannii phage vBAbaMpha0264 is GDMCC (China General Microbiological Culture Collection Center) NO: 66893-B1, and the preservation address of the acinetobacter baumannii phage vBAbaMpha0264 is Institute of Microbiology, Academy of Sciences, Guangdong. The bacteriophage vBAbaMpha0264 has high cracking activity, environmental stability and safety, shows a breakthrough host range, and can be used for effectively cracking a plurality of acinetobacter bacteria including hospital acinetobacter and acinetobacter sysei. Meanwhile, the bacteriophage has excellent chloroform tolerance, and the stability of the bacteriophage is obviously superior to that of the existing bacteriophage. Due to the characteristics, the phage vBAbaMpha0264 overcomes the technical prejudice of'narrow spectrum and instability 'of the traditional phage, and a brand new technical scheme is provided for developing a universal antibacterial preparation covering more pathogenic bacteria.

Pharmaceutical compositions and preparation including outer membrane vesicles (OMVs) and at least one pharmaceutically acceptable carrier wherein said OMVs are native OMVs produced by the Gram-negative commensal bacteria Bacteroides.

The present invention provides: a composition for controlling the proliferation of butyrate-producing bacteria, said composition comprising at least one substance selected from among sugar alcohols and derivatives thereof; a composition for controlling butyrate production, said composition comprising a sugar alcohol derivative; a composition for controlling the proliferation of bacteria of the genus Bifidobacterium, said composition comprising a sugar alcohol derivative; and uses of the same.

The present invention addresses the problem of providing a composition for controlling bacteria belonging to the genus Fusobacterium among the intestinal flora. The present invention provides a composition for controlling a bacterium belonging to the genus Fusobacterium in the intestinal flora, the composition comprising a bacterium belonging to the family Lactobacillus. The bacterium belonging to the genus fusobacterium is preferably a fusobacterium nucleatum (fusobacterium nucleatum), and the bacterium belonging to the genus fusobacterium is preferably a fusobacterium nucleatum (fusobacterium nucleatum). It is preferable that the bacterium belonging to the family Lactobacillus belong to a bacterium belonging to any genus selected from the group consisting of the genus Lactobacillus, the genus Lactobacillus, the genus Limosilbacilli, the genus Liiilbacilli, the genus Lactobacillus lactis, the genus Lactobacillus casei, and the genus Lactobacillus plantarum, and that the bacterium belonging to the family Lactobacillus is a bacterium belonging to any genus selected from the group consisting of the genus Lactobacillus, the genus Lactobacillus lactis, the genus Lactobacillus acidophilus, the genus Lactobacillus acidophilus, the genus Lactobacillus acidophilus, the genus Lactobacillus acidophilus, the genus Lactobacillus acidophilus and the genus Lactobacillus acidophilus.

The present invention belongs to the field of food products, in particular fresh mozzarella, and provides packing water suitable for directly acidified fresh mozzarella comprising at least one lactic acid bacterium (LAB), preferably wherein the at least one LAB strain is selected from a Lactobacillus strain, a Lactiplantibacillus strain, a Lacticaseibacillus strain or a Lactococcus strain. The invention further provides LAB suitable for being comprised in the packing water of the present invention and methods for producing packaged fresh mozzarella using the packing water and LAB of the present invention.

The present application belongs to the field of microbial technology, and particularly relates to a new bacterial strain of Acinetobacter sp. and its use. The bacterial strain is isolated from mangrove soil, is a new species of Acinetobacter sp., is named as Acinetobacter sp. GXMZU3951, and the bacteria have been registered and preserved in China General Microbiological Culture Collection Center (CGMCC) with a preservation number of CGMCC NO: 36553. The Acinetobacter sp. GXMZU3951 of the present application has iron carrier production activity, can produce higher indole acetic acid, and has the ability to promote plant growth and the potential to resist heavy metals. The present application can be used in the biological remediation of heavy metal contaminated soil and as a green and environment-friendly biofertilizer for improving crop production, and has a good development and application prospect.

A method of producing amino acids by fermentation in a bioreactor is disclosed, wherein the bioreactor includes methanogenic microorganisms in a fermentation broth, the method including at least the steps of feeding a gaseous carbon source including carbon dioxide and / or carbon monoxide, a nitrogen source and a sulfur source to the bioreactor under conditions such that the methanogenic microorganisms produce the amino acids; and harvesting at least a portion of the amino acids from the supernatant of the fermentation broth. Preferred methanogenic microorganisms are e.g. archaea selected from Methanothermobacter, Methanothermococcus and Methanococcus. Also provided is a fermentation broth comprising methanogenic microorganisms and amino acids in the supernatant, and a bioreactor including the same.

The invention provides a new application of the chlorine hydrozincite. The antibacterial agent according to the present invention is an antibacterial agent for at least one type of skin resident bacteria selected from the group consisting of Corynebacterium genus, Moraxella genus, and Malassezia genus, said antibacterial agent containing chlorine hydrozincite.

When fed to animals, Bacillus licheniformis strain O42AH3 (deposit accession number DSM 32559), Bacillus subtilis strain O52YJ6 (deposit accession number DSM 32560), Bacillus amyloliquefaciens strain O52YYT (deposit accession number DSM 32561) and / or Bacillus pumilis O72NR7 (deposit accession number DSM 32563) are useful for preventing and / or treating Lawsonia infections and for improving myriad performance parameters, including, but not limited to, body weight gain, average daily gain and feed conversion rates.

The present invention relates to bacterial strain Bacillus nakamurai CECT 30581, a microorganism of the gram-positive group of bacteria, genus Bacillus, and the metabolic products resulting from fermentation in the culture medium, total metabolic liquid (TML), hexane fraction (HF) and hexane subfraction (HS), nitrogen, phosphorous, potassium and manganese absorption stimulants in plants, and atmospheric CO2 fixation and transpiration, even under conditions of water stress. Once this strain has been isolated from the rhizosphere of Pinus pinaster and characterised from a physiological and genetic standpoint, the TML is separated / extracted and the metabolites responsible for the effects thereof, such as a characterisation profile of the bacterial products for different uses, are identified. Both the bacterial strain and its compositions can be used as the basis for producing different preparations intended to optimise the photosynthetic process of plants, improving plant growth and production in adverse situations of drought or reduced irrigation water. They can also be used within the field of organic biofertilisers to improve mineral nutrition in the indicated nutrients.

The present invention relates to a method for treating conditions associated with weight loss in emaciation and cachexia with a probiotic composition and the use of a probiotic composition in the treatment of conditions associated with weight loss in emaciation and cachexia. The present invention provides a method of treating a condition associated with weight loss, the method comprising administering to a subject considered in need of such treatment a probiotic composition wherein the composition comprises at least two bacteria, each preferably selected from a different genus, the genus is preferably selected from the group consisting of Lactobacillus genus, Enterococcus genus and Bifidobacterium genus. The present invention also provides a probiotic composition for use in the treatment of a subject suffering from a condition associated with weight loss wherein the composition comprises at least two bacteria each preferably selected from a different genus, preferably selected from the group consisting of Lactobacillus genus, Enterococcus genus and Bifidobacterium genus.

The invention provides an efficient marine ibuprofen degradation method based on an algae-bacterium co-culture system. In the algae-bacterium co-culture system, the bacterium is a bacillus strain Cytobacillus firus, and the algae is a cocoon-type algae acl-Entomonis Sp. The invention also discloses a preparation method of the algae-bacterium co-culture system. The method comprises the following steps: inoculating an algae-bacterium co-culture system into artificial simulated marine sewage containing ibuprofen, and fully mixing to obtain a mixed solution; and then culturing under proper culture conditions. The removal rate of ibuprofen within 10 days reaches 80.6%, and the method has the advantages of being low in energy consumption, environmentally friendly and suitable for marine pharmaceutical pollution remediation, and is a green biological technical scheme which is driven by solar energy and is ecologically sustainable.

The present invention relates to a composition that is used to primarily disrupt and remove biofilm from surfaces. This is achieved using a composition comprising a bacteriophage capable of lysing bacteria selected from one or more of Pseudomonas aeruginosa, Acinetobacter baumanii, Staphylococcus aureus, and E.coli; and a Bacillus bacterial spore in the presence of a specific surfactant of the poloxamer type.

The present invention relates to microorganisms for improving human and animal health. More particularly, the present invention relates to isolated Bacillus strains, as well as strains having all identification characteristics of these strains, for use including the above-mentioned use, in particular for improving gastrointestinal health in animals or humans.

The invention discloses an enterobacter hoffman JZ-3 strain and application thereof, and belongs to the technical field of microorganisms. The invention relates to an enterobacter hoffman strain JZ-3 with the preservation number of CGMCC No.33993. The degradation rate of the wool is 88.754%, and the degradation rate of the chicken feather is 34.222%. The specific activity is 127.420 U / mg when the pH value is 7 and the temperature is 30 DEG C. The invention also relates to application of the keratin degrading agent in preparation of keratin degrading products. Compared with the prior art, the invention has the following advantages: a plurality of bacteria are separated from intestinal tracts of costustotria moschata taking wool as food, a keratin culture medium is used for culturing to obtain bacterial strains with different wool keratin degradation capacities, the enterobacter hoffman JZ-3 which is inconsistent with that reported in literatures is found for the first time, the keratin bacterial strain of the bacterial strain has the highest specific activity, and the keratin bacterial strain has the highest specific activity. The degradation rate of the wool is 88.754%, and the wool degradation agent has good development value.

This invention discloses a lemongrass fermentation broth, its preparation method, and its application. The lemongrass fermentation broth simultaneously meets the following conditions: it contains live Lactiplantibacillus microorganisms, and the total number of live bacteria is ≥1×10⁻⁶. 9 The fermented lemongrass broth contains cfu / mL and contains volatile active ingredients, including at least linalool and methyl heptenone. Compared with unfermented lemongrass raw materials, the content of methyl heptenone in the lemongrass fermentation broth has increased from undetectable to over 10%, and the relative content of linalool has increased to over 20%. This invention's lemongrass fermentation broth possesses both a high viable bacterial count and a specific spectrum of volatile active ingredients. Through microbial fermentation, it achieves the targeted transformation of volatile components in lemongrass raw materials, particularly significantly increasing the content of linalool, methyl heptenone, and various ester aroma components, thus possessing broad prospects for industrial application.

The invention discloses a lactobacillus paragasseri strain capable of converting anthocyanin to generate various active metabolites, inhibiting NF-kappa B and cGAS-STING signals and enhancing inflammatory response relieving, and belongs to the technical field of microorganisms and the technical field of medicines. The lactobacillus paragasseri CCFM1499 provided by the invention can be used for converting anthocyanin into various active substances such as homovanillic acid, cyanidin, 3 ', 4'-dihydroxyphenylacetic acid and the like; fermentation supernate obtained by fermenting anthocyanin through the lactobacillus paragasseri CCFM1499 has the following effects: (1) the capability of reducing inflammatory factors of cells is achieved; (2) the cell senescence phenotypic capability is relieved; (3) the cGAS-STING signal channel capability is inhibited; and (4) inhibiting the NF-kappa B signal path capability. The lactobacillus paragasseri CCFM1499 fermented anthocyanin provided by the invention can be used for preparing a product for relieving inflammatory response, and has a huge application prospect.

The application discloses application of eugenol in preparation of a bacteriostatic agent for enhancing symbiotic nitrogen fixation efficiency of legume-rhizobium, and relates to the field of agricultural microorganisms. ‑1 The application is safe and non-inhibiting to seed germination of Medicago polymorpha and target rhizobium LL2 in a concentration range of 500-1000 muL / L ‑1 of eugenol, can significantly reshape rhizosphere microbial community structure by selectively inhibiting competitive microorganisms such as bacillus and streptomyces in soil, and is environment-friendly and free of antibiotic residue risk, thereby providing a green and efficient new approach for improving symbiotic nitrogen fixation efficiency of legume-rhizobium.